PeptiDream is a Japan-based drug discovery powerhouse that leverages its proprietary Peptide Discovery Platform System (PDPS) to discover and develop novel peptide-based therapeutics through collaborative research, technology licensing, and strategic partnerships with global pharmaceutical companies and research institutions. The company also operates a radiopharmaceutical business through its wholly-owned subsidiary PDR Pharma, which researches, manufactures, and sells diagnostic radiopharmaceuticals (SPECT and PET agents) and therapeutic radiopharmaceuticals primarily in oncology. PeptiDream aims to serve as the central hub of a global peptide drug discovery network and ecosystem, advancing next-generation medicines that transform patient outcomes.
Free demo (no time limit, up to 10 companies). Explore Comps, DCF, LBO, WACC on every screen. Excel export is on the paid plan.
Free Demo (No Time Limit, 10 Companies) →PeptiDream is a Japan-based drug discovery powerhouse that leverages its proprietary Peptide Discovery Platform System (PDPS) to discover and develop novel peptide-based therapeutics through collaborative research, technology licensing, and strategic partnerships with global pharmaceutical companies and research institutions. The company also operates a radiopharmaceutical business through its wholly-owned subsidiary PDR Pharma, which researches, manufactures, and sells diagnostic radiopharmaceuticals (SPECT and PET agents) and therapeutic radiopharmaceuticals primarily in oncology. PeptiDream aims to serve as the central hub of a global peptide drug discovery network and ecosystem, advancing next-generation medicines that transform patient outcomes.
Free demo (no time limit, up to 10 companies). Explore Comps, DCF, LBO, WACC on every screen. Excel export is on the paid plan.
Free Demo (No Time Limit, 10 Companies) →